Both in Pharmaceuticals
ALX Oncology Holdings vs Upstream Bio
Over the past year ALXO returned −17.8% and UPB returned −86.5%; their daily moves had a correlation of 0.27.
ALXO −17.8% UPB −86.5%Growth of $1, one year, split-adjusted
| Metric | ALXO | UPB |
|---|---|---|
| Price | $1.29 | $3.39 |
| Market cap | $178.4M | $185.7M |
| Today | −5.84% | +1.19% |
| 1 month | +6.6% | −30.1% |
| 6 months | −33.2% | −62.8% |
| Year to date | +14.2% | −87.5% |
| 1 year | −16.2% | −86.9% |
| Revenue growth (YoY) | — | −17.5% |
| Gross margin | — | 100.0% |
| Net margin | — | −5136.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 58.8× |
| Net cash | $128.5M | $261.3M |
| Dividend yield | — | — |
| Volatility (60d) | 93.1% | 82.1% |
| Short % of float | 6.5% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).